CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

PI Industries jumps 5 per cent as board approves acquisition of API business of Ind-Swift Labs
DSIJ Intelligence
/ Categories: Trending, Mindshare

PI Industries jumps 5 per cent as board approves acquisition of API business of Ind-Swift Labs

The overall purchase consideration will be Rs 1,530 crore. The purchase consideration will be paid in all cash and funded from the proceeds of the completed qualified institutional placement (QIP) and internal accruals.

PI Industries on July 31, 2021, executed a business transfer agreement (BTA) with Ind-Swift Laboratories Limited (ISLL) for the acquisition of their API and intermediates business undertaking on a slump sale going concern basis. 

The overall purchase consideration will be Rs 1,530 crore. The purchase consideration will be paid in all cash and funded from the proceeds of the completed qualified institutional placement (QIP) and internal accruals. The transaction is expected to be earnings accretive with immediate effect. The target entity will be acquired through PI’s fully-owned subsidiary. 

The transaction includes the entire API undertaking of Ind-Swift Laboratories, which includes two manufacturing plants located in Punjab and Jammu & Kashmir. R&D centre is set up in Mohali (Punjab) with a robust product pipeline, customer and vendor contracts, marketing, distribution as well as sales networks spanning more than 70 countries, serving more than 200+ global customers. 

The acquired undertaking has cGMP-compliant manufacturing facilities with approvals for US (USFDA), European, Japanese, Europe (EDQM), Japan (PMDA), Brazil (ANVISA), Korea (KFDA), and other markets. 

The integration of the target entity into the corporate structure of PI is expected to be completed during Q3FY22, subject to fulfilment of customary closing conditions and regulatory approvals. 

PI Industries Ltd is a leading player in the agro-chemicals space having a strong presence in both domestic and export markets. It has state-of-art facilities in Gujarat, having integrated process development teams with in-house engineering capabilities. 

The shares of PI Industries touched a high of Rs 3,089 per share on BSE during the early market hours on August 2, 2021 (Monday). 

Previous Article In interaction with Krishnakumar V, Executive Director & COO at Eris Lifesciences
Next Article Realty Stocks rally; Godrej Properties trades at life highs
Print
1383 Rate this article:
3.7
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR